Rachel Sachs, associate professor of law
Last year was an unquestionably busy time for health care news of all kinds. Media and policy coverage rightly focused on the many attempts to repeal the Affordable Care Act, but it was also an eventful year in news for those of us who focus on prescription drug policy. In this post, I review five of the biggest drug policy developments of the past year, and look ahead to five issues I expect to make headlines in 2018.
Like 2017, drug policy watchers should expect 2018 to be a year full of interesting news. Here’s hoping it is also a year for policymakers to find solutions to some of the many challenges in drug policy.
Read the full piece at Health Affairs.